What is M2i Life Sciences?
M2i Life Sciences, a prominent entity in the biocontrol solutions market, specializes in advanced technologies for both plant and animal applications. Leveraging proprietary molecules and sophisticated micro-encapsulation techniques, the company is dedicated to developing sustainable and effective products. With a robust global footprint supported by extensive research and development infrastructure, M2i Life Sciences offers a comprehensive catalog for product ordering and actively pursues strategic partnerships for collaborative innovation. Its commitment to responsible practices and pioneering advancements has garnered industry recognition and multiple awards, reinforcing its mission and core values.
How much funding has M2i Life Sciences raised?
M2i Life Sciences has raised a total of $13.5M across 1 funding round:
Private Equity
$13.5M
Private Equity (2017): $13.5M with participation from Idinvest Partners
Key Investors in M2i Life Sciences
Idinvest Partners
Idinvest Partners is a mid-market private equity firm founded in 1997 and headquartered in Paris, France. They specialize in financing and supporting entrepreneurs across various business development stages.
What's next for M2i Life Sciences?
The substantial enterprise-level funding M2i Life Sciences has attracted signals a pivotal phase of expansion and further technological development. This strategic investment is expected to fuel the company's global reach and enhance its research capabilities, particularly in its specialized areas of biocontrol for agriculture and animal health. Future growth will likely involve scaling production, broadening its product portfolio, and solidifying its market leadership through continued innovation and strategic alliances.
See full M2i Life Sciences company page
